CKD-504 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

---

臨床試験数 : 242 /  薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03713892 (ClinicalTrials.gov)	May 23, 2018	17/10/2018	CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects	Phase I Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, PK, PD of CKD-504 in Single SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects	Huntington Disease	Drug: CKD-504;Drug: Placebo	Chong Kun Dang Pharmaceutical	NULL	Recruiting	19 Years	45 Years	All	88	Phase 1	Korea, Republic of